Investment Summary

Exits Nevro

On November 6, 2014, invested in medical products company Nevro from Bay City Capital and Three Arch Partners

Investment Highlights
  • This is transaction in the Medical Products sector.
  • This is transaction in the United States.
  • This is transaction in California.

Investment Summary

Date 2014-11-06
Target Nevro
Sector Medical Products
Sellers(s) Bay City Capital
Three Arch Partners
Deal Type IPO

Target

Nevro

Redwood City, California, United States
website
Nevro is a medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro was founded in 2006 and is based in Redwood City, California.

Search 177,612 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Seller(S) 2

SELLER

Bay City Capital

San Rafael, California, United States

Investor Investor Investor Investor Investor

website


Category Venture Capital Firm
Founded 1997
PE ASSETS 1.3B USD
Size Large
Type Sector Focused
DESCRIPTION

Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.


DEAL STATS #
Overall 54 of 62
Sector (Medical Products) 10 of 10
Type (IPO) 22 of 23
State (California) 29 of 33
Country (United States) 52 of 59
Year (2014) 6 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-10-24 Aciex Therapeutics

Boston, Massachusetts, United States

Aciex Therapeutics, Inc. is an ophthalmic pharmaceutical company centered on developing first in class products to treat ocular diseases.

Sell $120M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-10-20 Merus BV

Utrecht, Netherlands

Merus BV is a fully-integrated biotechnology company developing cancer therapeutics that combine the benefits of monoclonal antibodies with the ability of simultaneously addressing multiple targets.

Sell -
SELLER

Three Arch Partners

San Mateo, California, United States

website


Category Private Equity Firm
Founded 1993
PE ASSETS 1.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Three Arch Partners is an investor in healthcare companies, including medical devices, diagnostics, and healthcare services. Three Arch primarily invests in early stage companies, however the Firm will consider select later stage investments. Three Arch typically invests alongside others and looks to commit $100k to $15 million per investment. Three Arch Partners was formed in 1993 and is based in San Mateo, California.


DEAL STATS #
Overall 20 of 24
Sector (Medical Products) 13 of 14
Type (IPO) 6 of 6
State (California) 16 of 17
Country (United States) 20 of 24
Year (2014) 4 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-05-12 AccessClosure

Santa Clara, California, United States

AccessClosure, Inc. is a medical device company that is pioneering innovative access site management products designed to address the complex challenge of vascular closure during interventional and diagnostic procedures.

Sell $320M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-11-12 Centerre Healthcare

Brentwood, Tennessee, United States

Centerre Healthcare is a provider of physical rehabilitation. Centerre Healthcare has the experience and resources to create highly successful rehabilitation hospitals while meeting the clinical and financial requirements of its partner hospitals.

Sell $195M